PC is particularly diffused in countries where advanced screening protocols (e.g., prostate-specific antigen (PSA) detection, MRI, and prostate biopsy) are available [2], accounting for more than 350,000 deaths per year [3]. Here, KLK3 is linked to pachyonychia congenita.